IEQ Capital’s Xeris Biopharma Holdings XERS Stock Holding History

IEQ Capital’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$780K	Buy	98,429 +16,799	+21%	+$107K	﹤0.01%	1221
2026 Q1	$473K	Sell	81,630 -4,890	-6%	-$32.4K	﹤0.01%	1332
2025 Q4	$679K	Sell	86,520 -21,433	-20%	-$169K	﹤0.01%	1192
2025 Q3	$879K	Sell	107,953 -542	-0.5%	-$3.6K	﹤0.01%	1057
2025 Q2	$507K	Sell	108,495 -46,689	-30%	-$214K	﹤0.01%	1152
2025 Q1	$852K	Buy	155,184 +87,469	+129%	+$353K	0.01%	803
2024 Q4	$230K	Buy	67,715 +13,322	+24%	+$42.9K	﹤0.01%	1146
2024 Q3	$155K	Hold	54,393	–	–	﹤0.01%	1079
2024 Q2	$122K	Hold	54,393	–	–	﹤0.01%	944
2024 Q1	$120K	Buy	54,393 +4,224	+8%	+$10.9K	﹤0.01%	919
2023 Q4	$118K	Hold	50,169	–	–	﹤0.01%	877
2023 Q3	$93.3K	Hold	50,169	–	–	﹤0.01%	896
2023 Q2	$131K	Hold	50,169	–	–	﹤0.01%	836
2023 Q1	$81.8K	Hold	50,169	–	–	﹤0.01%	860
2022 Q4	$66.7K	Hold	50,169	–	–	﹤0.01%	786
2022 Q3	$78K	Hold	50,169	–	–	﹤0.01%	811
2022 Q2	$77K	Hold	50,169	–	–	﹤0.01%	775
2022 Q1	$128K	Hold	50,169	–	–	﹤0.01%	783
2021 Q4	$147K	Buy	+50,169	New	+$108K	﹤0.01%	706

Other funds holding XERS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

IEQ Capital's XERS Position: Q2 2026 in Review

IEQ Capital increased its Xeris Biopharma Holdings (XERS) stake by 21% in Q2 2026, buying an estimated $107K and bringing the position to 98,429 shares worth $780K. The position accounts for ﹤0.01% of the portfolio, ranked #1221.

IEQ Capital first reported a position in XERS in Q4 2021 and has held it in 19 quarters since. The position peaked at $879K in Q3 2025. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

IEQ Capital held 98,429 shares of Xeris Biopharma Holdings worth $780K as of Q2 2026.
IEQ Capital bought 16,799 Xeris Biopharma Holdings shares in Q2 2026, an estimated $107K.
Xeris Biopharma Holdings made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1221 holding.
IEQ Capital first reported a position in Xeris Biopharma Holdings in Q4 2021 and has held it in 19 quarters since.
IEQ Capital's Xeris Biopharma Holdings position peaked at $879K in Q3 2025.
241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.